LinkedIn Profile

Access Greyson International historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:greysoninternational 6376836 May 28th, 2019 12:00AM Greyson International Inc. 4 2.00 Open Pharmaceuticals May 28th, 2019 03:19PM May 28th, 2019 03:19PM Greyson International is an R&D pharmaceutical company that develops enhanced, patent protected dermatology and healthcare products including products and various other medical treatments using its patented technology Trilexon®. Greyson International's primary objective is to license these prescription and over-the-counter products into the $65 billion global dermatology market and other medical markets. Potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products, product enhancements or life cycle management for their existing products. Open Trilexon®, Patented Technology, Pharmaceutical & Cosmetic Partnering, Licensing, Strategic Alliance Open Greyson International Consumer Goods Pharmaceuticals & Biotechnology
private:greysoninternational 6376836 Mar 18th, 2018 12:00AM Greyson International Inc. 3 2.00 Open Pharmaceuticals Mar 18th, 2018 06:41PM Mar 18th, 2018 06:41PM Open Greyson International Consumer Goods Pharmaceuticals & Biotechnology
private:greysoninternational 6376836 Feb 17th, 2018 12:00AM Greyson International Inc. 3 2.00 Open Pharmaceuticals Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Greyson International is an R&D pharmaceutical company that develops enhanced, patent protected dermatology and healthcare products including products and various other medical treatments using its patented technology Trilexon®. Greyson International's primary objective is to license these prescription and over-the-counter products into the $65 billion global dermatology market and other medical markets. Potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products, product enhancements or life cycle management for their existing products. Greyson International Consumer Goods Pharmaceuticals & Biotechnology
private:greysoninternational 6376836 Feb 16th, 2018 12:00AM Greyson International Inc. 3 2.00 Open Pharmaceuticals Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Greyson International is an R&D pharmaceutical company that develops enhanced, patent protected dermatology and healthcare products including products and various other medical treatments using its patented technology Trilexon®. Greyson International's primary objective is to license these prescription and over-the-counter products into the $65 billion global dermatology market and other medical markets. Potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products, product enhancements or life cycle management for their existing products. Greyson International Consumer Goods Pharmaceuticals & Biotechnology
private:greysoninternational 6376836 Feb 15th, 2018 12:00AM Greyson International Inc. 3 2.00 Open Pharmaceuticals Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Greyson International is an R&D pharmaceutical company that develops enhanced, patent protected dermatology and healthcare products including products and various other medical treatments using its patented technology Trilexon®. Greyson International's primary objective is to license these prescription and over-the-counter products into the $65 billion global dermatology market and other medical markets. Potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products, product enhancements or life cycle management for their existing products. Greyson International Consumer Goods Pharmaceuticals & Biotechnology
private:greysoninternational 6376836 Feb 14th, 2018 12:00AM Greyson International Inc. 3 2.00 Open Pharmaceuticals Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Greyson International is an R&D pharmaceutical company that develops enhanced, patent protected dermatology and healthcare products including products and various other medical treatments using its patented technology Trilexon®. Greyson International's primary objective is to license these prescription and over-the-counter products into the $65 billion global dermatology market and other medical markets. Potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products, product enhancements or life cycle management for their existing products. Greyson International Consumer Goods Pharmaceuticals & Biotechnology
private:greysoninternational 6376836 Feb 13th, 2018 12:00AM Greyson International Inc. 3 2.00 Open Pharmaceuticals Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Greyson International is an R&D pharmaceutical company that develops enhanced, patent protected dermatology and healthcare products including products and various other medical treatments using its patented technology Trilexon®. Greyson International's primary objective is to license these prescription and over-the-counter products into the $65 billion global dermatology market and other medical markets. Potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products, product enhancements or life cycle management for their existing products. Greyson International Consumer Goods Pharmaceuticals & Biotechnology
private:greysoninternational 6376836 Feb 12th, 2018 12:00AM Greyson International Inc. 3 2.00 Open Pharmaceuticals Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Greyson International is an R&D pharmaceutical company that develops enhanced, patent protected dermatology and healthcare products including products and various other medical treatments using its patented technology Trilexon®. Greyson International's primary objective is to license these prescription and over-the-counter products into the $65 billion global dermatology market and other medical markets. Potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products, product enhancements or life cycle management for their existing products. Greyson International Consumer Goods Pharmaceuticals & Biotechnology
private:greysoninternational 6376836 Feb 11th, 2018 12:00AM Greyson International Inc. 3 2.00 Open Pharmaceuticals Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Greyson International is an R&D pharmaceutical company that develops enhanced, patent protected dermatology and healthcare products including products and various other medical treatments using its patented technology Trilexon®. Greyson International's primary objective is to license these prescription and over-the-counter products into the $65 billion global dermatology market and other medical markets. Potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products, product enhancements or life cycle management for their existing products. Greyson International Consumer Goods Pharmaceuticals & Biotechnology
private:greysoninternational 6376836 Feb 10th, 2018 12:00AM Greyson International Inc. 3 2.00 Open Pharmaceuticals Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Greyson International is an R&D pharmaceutical company that develops enhanced, patent protected dermatology and healthcare products including products and various other medical treatments using its patented technology Trilexon®. Greyson International's primary objective is to license these prescription and over-the-counter products into the $65 billion global dermatology market and other medical markets. Potential licensees include international and multi-national pharmaceutical, cosmetic, skincare and consumer goods companies seeking new products, product enhancements or life cycle management for their existing products. Greyson International Consumer Goods Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.